Latest Articles
- Diabetes therapy and cancer risk: Where do we stand when treating patients?
Several classes of diabetes drugs are under scrutiny for potentially promoting cancer in a population already at risk.
- To dream the maybe possible dream: A breast cancer vaccine
The work is in an extremely preliminary phase, but the concept is an active area of research worth keeping tabs on.
- Bench-to-bedside challenges in developing immune protection against breast cancer
A vaccine against breast cancer is being developed. Here, the author explains the principles and challenges.
- Keeping up with immunizations for adults
Flu, tetanus, measles, mumps, rubella, varicella, hepatitis A and B, human papillomavirus, zoster, pneumonia, and meningitis.
- Should all patients have a resting 12-lead ECG before elective noncardiac surgery?
If the risk is low, an ECG could unnecessarily delay surgery, drive up costs, trigger further testing, and increase anxiety.
When patients on target-specific oral anticoagulants need surgeryUntil evidence-based guidelines are developed, clinicians will have to apply their knowledge of pharmacology.
- In Reply: Stress testing (July 2014)
A reader comments on stress testing in asymptomatic patients at low risk (July 2014).
- The protein-sparing modified fast for obese patients with type 2 diabetes: What to expect
Committed patients can lose weight and control their diabetes, but they need encouragement and close supervision.
- Polycystic kidney disease: Molecular understanding dictating management
It was the early 1980s, I was a resident in the emergency room, and the patient had fever, flank pain, hypotension, and a normal urinalysis.